Session 12 of 12: Whose Ending Is This?
Daniel, 29, has completed 11 of 12 authorized sessions for generalized anxiety. His GAD-7 fell from 17 to 7; he now sleeps through the night. His remaining goals were public-speaking avoidance and reducing alcohol. He has not progressed past step two of the exposure hierarchy, and his AUDIT-C rose from 2 to 7 in the past month. He asks to continue weekly, indefinitely, and offers to pay out of pocket. Your clinic director notes a 40-person waitlist and asks you to close the case at session 12. Your supervisor comments that you are 'the best thing he has,' a remark you notice you liked hearing.
1. Should you terminate at session 12? Lay out how you decide, and what you tell the clinic director.
Read the worked answer
Separate three questions that are being merged: Is he clinically ready to end? Would ending now cause harm? What administrative pressures exist? Only the first two are clinical.
What the data say. A GAD-7 drop from 17 to 7 exceeds the reliable change index for that measure and lands below the clinical cutoff of 10 - that is genuine, reliable improvement, not just a good mood in the room. But two contracted goals are unmet: exposure stalled at step two (avoidance is the maintaining mechanism in GAD), and AUDIT-C rose from 2 to 7, crossing into the moderate-risk zone for men. That is a partial response with one domain deteriorating.
Clinical conclusion: ending at 12 is premature, but indefinite weekly supportive therapy is not a treatment plan either. The right move is a re-contract with a defined horizon, not a passive extension and not an abrupt close.
What you tell the director - in writing:
- Reliable improvement on the primary measure, with two unmet goals.
- A rising alcohol screen that was never addressed; closing now would abandon a finding.
- A proposed 4-6 session focused phase targeting exposure and drinking, with a hard review point and a taper plan, and clear criteria for discharge to the waitlist.
- Note the access problem honestly: a 40-person waitlist is an agency resource issue, not a clinical indication to end a case mid-work.
On the remark you liked hearing: indefinite continuation so that you can remain 'the best thing he has' is your countertransference, not Daniel's treatment need. Name it to yourself or in supervision. Note also that paying out of pocket is legitimate - insurance limits are not clinical limits, and step-down to biweekly and then monthly is a defensible middle path.
2. Design the ending concretely: what happens in session 12 and over the following months?
Read the worked answer
Session 12 - make the data the shared object. Show him the plotted GAD-7 and AUDIT-C. Name what changed and what did not, in his language and yours. Then propose:
A defined focused phase (sessions 13-18), with a scheduled review at 18:
- Exposure: complete steps 3-8 with SUDS ratings, one planned exposure per week, in-session rehearsal and between-session tasks.
- Alcohol: drink diary, brief intervention, psychoeducation about anxiety and alcohol as mutual maintenance, repeat AUDIT-C in 6 weeks, referral to a higher level of care if indicated. Screen for an alcohol use disorder rather than treating 7 as a lifestyle number.
Taper, then boosters. Weekly → biweekly → monthly, with scheduled check-ins at 1 and 3 months post-termination. Measure at each booster; a taper with measurement is a termination plan, a taper without one is a hope.
Relapse-prevention plan, written and shared: his early-warning signature (sleep disruption, cancellation of social plans, drinking on weeknights), a coping menu, a card for 'what to do at 3 a.m.,' and an explicit statement that he may request one session without re-entering full treatment.
Administrative close-out: termination summary in the record, discharge criteria stated in advance, coordination with any prescriber, and - if the agency forces a close at 12 - a warm handoff to a named clinician, not a voicemail with referral numbers.
Watch the boundary in the ending: he asked for weekly indefinitely, and you noticed you liked being needed. A planned ending that he helped design is treatment. An ending he talked you out of is a boundary failure wearing a clinical costume.
3. At session 13 Daniel says therapy is 'just a crutch,' that he is done, and cancels the rest. What is your response?
Read the worked answer
First, assess, do not argue. Abrupt self-termination after a rise in drinking and stalled exposure is a risk signal, not a sign of health. Ask directly about hopelessness, drinking, sleep, and functioning; use a structured check if there is any indication. Respect autonomy, but do not confuse respect with abdication.
Look for what the 'crutch' language is defending against. Shame about the alcohol, fear of the exposure work, or a reaction to the ending being forced by the clinic. Ask: what happened between last session and this call? The answer is usually more useful than a debate about crutches.
Concrete steps:
- Offer one closing session, framed as a review, not a negotiation about continuing.
- If he declines, send a brief written summary with crisis resources and an explicit invitation to return.
- Document capacity, the risk assessment, the advice given, and his choice.
- With his consent, arrange a 30-day check-in call or message.
- Do not chase. Two contacts is advocacy; five is coercion.
The ethical frame: non-abandonment does not mean override the client's autonomy. It means the door is visibly open, the risk was assessed, the alternatives were offered in writing, and the record shows it. If he deteriorates after this, re-open the case rather than telling him he was discharged.